Vercirnon
Title | Journal |
---|---|
A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease. | Journal of medicinal chemistry 20160414 |
Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. | The Journal of pharmacology and experimental therapeutics 20101001 |